|

LY4052031 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Eli Lilly and Company1

Indications

  • Urinary Bladder Neoplasm1
  • Recurrent Solid Tumor1
  • Renal Pelvis Cancer1
  • Metastatic Solid Tumor1
  • Triple Negative Breast Cancer1

Duarte, California1 trial

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

City of Hope National Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.